Brown Capital Management - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Brown Capital Management ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$98,209,000
+90.0%
452,783
+1.1%
0.73%
+104.8%
Q4 2020$51,684,000
+39.6%
447,828
+17.8%
0.36%
+16.3%
Q3 2020$37,014,000
-8.3%
380,217
+15.7%
0.31%
-11.5%
Q2 2020$40,343,000
+58.4%
328,739
+13.0%
0.35%
+17.6%
Q1 2020$25,468,000
-3.2%
290,830
+15.6%
0.30%
+17.1%
Q4 2019$26,314,000
+0.6%
251,664
+10.7%
0.25%
-0.8%
Q3 2019$26,151,000
-6.9%
227,338
+39.5%
0.25%
-4.5%
Q2 2019$28,088,000
+48.6%
162,934
+45.3%
0.27%
+39.3%
Q1 2019$18,898,000
+129.8%
112,107
+32.7%
0.19%
+92.9%
Q4 2018$8,225,000
-5.2%
84,453
+68.2%
0.10%
+25.3%
Q3 2018$8,672,000
+33.3%
50,203
+7.6%
0.08%
+17.9%
Q2 2018$6,508,000
+52.3%
46,642
+23.0%
0.07%
+36.7%
Q1 2018$4,274,000
-13.1%
37,930
+1.7%
0.05%
-18.3%
Q4 2017$4,921,000
+43.6%
37,280
+10.4%
0.06%
+42.9%
Q3 2017$3,427,000
+6.7%
33,769
+5.4%
0.04%
+7.7%
Q2 2017$3,213,000
-14.1%
32,049
+3.6%
0.04%
-22.0%
Q1 2017$3,741,000
+16.1%
30,936
+7.3%
0.05%
+6.4%
Q4 2016$3,223,00028,8440.05%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
Copernicus Capital Management, LLC 52,488$5,110,0004.87%
GREAT POINT PARTNERS LLC 520,232$50,645,0004.56%
Integral Health Asset Management, LLC 65,000$6,328,0001.94%
CLOUGH CAPITAL PARTNERS L P 190,716$18,566,0001.34%
Parkman Healthcare Partners LLC 50,000$4,868,0001.29%
ETF MANAGERS GROUP, LLC 375,344$36,540,0001.16%
Redwood Investments, LLC 124,094$12,081,0001.02%
Eventide Asset Management 436,000$42,445,0000.83%
Bellevue Group AG 562,943$54,803,0000.76%
ROOSEVELT INVESTMENT GROUP LLC 95,499$9,297,0000.75%
View complete list of GW PHARMACEUTICALS PLC shareholders